Index P

p53 gene: Sec. 3, Ch. 51

PACE (Program of All-Inclusive Care for the Elderly): Sec. 4, Ch. 66

Pacemaker

artificial: Sec. 3, Ch. 47; Sec. 3, Ch. 47

     in abnormal heart rhythms: Sec. 3, Ch. 47

     in heart block: Sec. 3, Ch. 47

     in heart failure: Sec. 3, Ch. 46

natural: Sec. 3, Ch. 47

Pads

for incontinence: Sec. 3, Ch. 57

Paget's disease

of breast: Sec. 3, Ch. 51

hearing loss in: Sec. 3 Ch. 37 [detail]; Sec. 3, Ch. 37

high calcium level in: Sec. 3, Ch. 18

information resources on: 888

of vulva: Sec. 3, Ch. 51

Pain: Sec. 3, Ch. 24

in acid reflux: Sec. 3, Ch. 54

acupuncture for: Sec. 2, Ch. 7

angina: Sec. 3, Ch. 44; Sec. 3, Ch. 45; Sec. 3, Ch. 45; Sec. 3, Ch. 45

abnormal heart rhythms with: Sec. 3, Ch. 47

in atherosclerosis: Sec. 3, Ch. 44

back

     chiropractic for: Sec. 2, Ch. 7

     osteoarthritis and: Sec. 3, Ch. 41

     after spinal fracture: Sec. 3, Ch. 23

bursa: Sec. 3 Ch. 41 [sidebar]

in cancer: Sec. 3, Ch. 50; Sec. 3, Ch. 50; Sec. 3, Ch. 50

chest: (see Chest, pain in)

     in heart valve disorders: Sec. 3, Ch. 48

in deep vein thrombosis: Sec. 3, Ch. 44

in dementia: Sec. 3, Ch. 27

drugs for: Sec. 3, Ch. 24

during exercise: Sec. 3, Ch. 60

during rehabilitation: Sec. 2, Ch. 13

during testing: Sec. 2, Ch. 10

face

     in trigeminal neuralgia: Sec. 3, Ch. 29

with falls: Sec. 3, Ch. 21

foot: Sec. 3, Ch. 40

with fracture: Sec. 3, Ch. 23

in gout: Sec. 3, Ch. 41

in heart attack: Sec. 3 Ch. 45 [sidebar]

with hip fracture: Sec. 3, Ch. 23

in influenza: Sec. 3, Ch. 52

joint: Sec. 3, Ch. 41

after leg amputation: Sec. 2, Ch. 13

leg

     in deep vein thrombosis: Sec. 3, Ch. 44

     in diabetes: Sec. 3, Ch. 34

     in peripheral arterial disease: Sec. 3, Ch. 44

in lung cancer: Sec. 3, Ch. 51

magnet therapy for: Sec. 2, Ch. 7

in multiple myeloma: Sec. 3, Ch. 51

near joints: Sec. 3 Ch. 41 [sidebar]

neuropathic: Sec. 2, Ch. 16

nociceptive: Sec. 3 Ch. 24 [detail]

in peripheral arterial disease: Sec. 3, Ch. 44; Sec. 3, Ch. 44

in polymyalgia: Sec. 3, Ch. 42

postherpetic: Sec. 3, Ch. 24; Sec. 3, Ch. 24; Sec. 3, Ch. 29; Sec. 3, Ch. 35; Sec. 3, Ch. 35; Sec. 3, Ch. 35

in prostate cancer: Sec. 3, Ch. 51

in prostatitis: Sec. 3, Ch. 59

in pseudogout: Sec. 3, Ch. 41

receptors for: Sec. 3 Ch. 24 [detail]

referred: Sec. 3, Ch. 24; Sec. 3, Ch. 24

sensitivity to: Sec. 1, Ch. 2

after shingles: Sec. 3, Ch. 24; Sec. 3, Ch. 24; Sec. 3, Ch. 35; Sec. 3, Ch. 35; Sec. 3, Ch. 35

after surgery: Sec. 2, Ch. 12

in swallowing difficulty: Sec. 3, Ch. 54

in temporal arteritis: Sec. 3, Ch. 42

tendon: Sec. 3 Ch. 41 [sidebar]

treatment of: Sec. 3, Ch. 24

     information resources on: 888

vulvar: Sec. 3, Ch. 58

Palliative care: Sec. 2, Ch. 16

in cancer: Sec. 3, Ch. 50; Sec. 3, Ch. 51

referral for: Sec. 2, Ch. 16

vs. hospice care: Sec. 2, Ch. 16

Pallidotomy

in dystonia: Sec. 3, Ch. 30

in Parkinson's disease: Sec. 3, Ch. 30

information resources on: 888

Palpitations: (see also Arrhythmias)

in abnormal heart rhythms: Sec. 3, Ch. 47; Sec. 3, Ch. 47

in coronary artery disease: Sec. 3, Ch. 45

fainting with: Sec. 3 Ch. 20 [sidebar]

in heart valve disorders: Sec. 3, Ch. 48

Pamidronate

in multiple myeloma: Sec. 3, Ch. 51

in osteoporosis: Sec. 3, Ch. 22

Pancreatitis

low calcium level in: Sec. 3, Ch. 18

Panic disorder: Sec. 3 Ch. 32 [detail]

Pap test

in vaginal bleeding: Sec. 3, Ch. 58

Paraffin bath: Sec. 2, Ch. 13

Paralysis

after stroke: Sec. 2, Ch. 13

vocal cord: Sec. 3, Ch. 38

Paranasal sinuses: Sec. 3, Ch. 38

inflammation of (sinusitis): Sec. 3, Ch. 38

Paranoia: Sec. 3, Ch. 32

Paraphrenia: Sec. 3, Ch. 32

Parathyroid hormone

excess of: Sec. 3, Ch. 18

low levels of: Sec. 3, Ch. 18

synthetic: Sec. 3, Ch. 22; Sec. 3, Ch. 22

Parkinson's disease: Sec. 3, Ch. 30

dementia in: Sec. 3 Ch. 27 [sidebar]

exercise in: Sec. 3, Ch. 60

information resources on: 888

orthostatic hypotension in: Sec. 3, Ch. 20

swallowing difficulty in: Sec. 3, Ch. 54

undernutrition and: Sec. 3 Ch. 17 [detail]

Parkinsonism: Sec. 3 Ch. 30 [sidebar]

Paroxetine

in depression: Sec. 3, Ch. 32

St. John's wort interaction with: Sec. 2, Ch. 7

Pelvic (Kegel) exercises: Sec. 3, Ch. 60

in incontinence: Sec. 3, Ch. 57

Pelvic examination

in urinary incontinence: Sec. 3, Ch. 57

in vaginal bleeding: Sec. 3, Ch. 58

Pelvic support disorders: Sec. 3, Ch. 58

constipation and: Sec. 3, Ch. 55

Penbutolol

in abnormal heart rhythms: Sec. 3, Ch. 47

in coronary artery disease: Sec. 3, Ch. 45

in heart failure: Sec. 3, Ch. 46

in high blood pressure: Sec. 3, Ch. 43

Penicillamine: Sec. 3, Ch. 41

Penis

erectile failure of: Sec. 3, Ch. 59

     failure of (erectile dysfunction): 886

scarring in: Sec. 3 Ch. 59 [detail]

Pentazocine: Sec. 2, Ch. 6

Percutaneous transluminal coronary angioplasty (PTCA): Sec. 3, Ch. 45

Performance test: Sec. 2, Ch. 10

Pergolide: Sec. 3, Ch. 30

Pericardial effusion: Sec. 3, Ch. 44

Pericarditis

in influenza: Sec. 3, Ch. 52; Sec. 3, Ch. 52

Perindopril

in coronary artery disease: Sec. 3, Ch. 45

in heart failure: Sec. 3, Ch. 46

Periodic limb movements of sleep: Sec. 3, Ch. 31

Periodontitis: Sec. 3, Ch. 39

Peripheral arterial (vascular) disease: Sec. 3, Ch. 44; Sec. 3, Ch. 44

exercise in: Sec. 3, Ch. 60

Peristalsis: Sec. 3, Ch. 54

Pernicious anemia: Sec. 3, Ch. 49

Peroneal vein: Sec. 3, Ch. 44

Perphenazine: Sec. 3, Ch. 32

Personal emergency response system: Sec. 3, Ch. 21

for fainting disorder: Sec. 3, Ch. 20

Personality

changes in

     in Alzheimer's disease: Sec. 3, Ch. 27

     in dementia: Sec. 3, Ch. 27

Pessary: Sec. 3, Ch. 58

PET: (see Positron emission tomography)

Pets: Sec. 4, Ch. 63

Peyronie's disease: Sec. 3 Ch. 59 [detail]

pH

esophageal: Sec. 3, Ch. 54

Phantom limb sensation: Sec. 2, Ch. 13

Pharmacist: Sec. 2, Ch. 9; Sec. 2, Ch. 9

partnership with: Sec. 2, Ch. 6

Pharynx: (see Throat)

Phenazopyridine: Sec. 3, Ch. 56

Phenelzine

Phenobarbital: Sec. 2, Ch. 6

medicinal herb interactions with: Sec. 2, Ch. 7

vitamin D deficiency and: Sec. 3, Ch. 18

Phenothiazines

swallowing difficulty with: Sec. 3, Ch. 54

Phenytoin

in abnormal heart rhythms: Sec. 3, Ch. 47

gum growth with: Sec. 3, Ch. 39

vitamin D deficiency and: Sec. 3, Ch. 18

Phlebotomy: Sec. 3, Ch. 49

Phlegm

in chronic bronchitis: Sec. 3, Ch. 53

in COPD: Sec. 3, Ch. 53; Sec. 3, Ch. 53

in influenza: Sec. 3, Ch. 52

in pneumonia: Sec. 3, Ch. 52; Sec. 3, Ch. 52

Phobic disorders: Sec. 3 Ch. 32 [detail]

Phosphorus

deficiency of: Sec. 3, Ch. 17

Phototherapy

in circadian rhythm disorders: Sec. 3, Ch. 31

in seasonal affective disorder: Sec. 3, Ch. 32

Physiatrist: Sec. 2, Ch. 9

Physical abuse: Sec. 4, Ch. 64

Physical activity (see also Exercise)

muscle strength and: Sec. 1, Ch. 2

Physical examination: Sec. 2, Ch. 10

Physical inactivity: (see also Bed rest)

atherosclerosis and: Sec. 3, Ch. 44

problems related to: Sec. 1, Ch. 2

Physical therapist: Sec. 2, Ch. 9

Physical therapy: Sec. 2, Ch. 13

in dystonia: Sec. 3, Ch. 30

after fracture treatment: Sec. 3, Ch. 23

for heart disorders: Sec. 2, Ch. 13

after hip replacement: Sec. 2, Ch. 13

after knee replacement: Sec. 2, Ch. 13

after leg amputation: Sec. 2, Ch. 13

in osteoarthritis: Sec. 3, Ch. 41

in Parkinson's disease: Sec. 3, Ch. 30

in rheumatoid arthritis: Sec. 3, Ch. 41

after stroke: Sec. 2, Ch. 13; Sec. 3, Ch. 28

Physician assistant: Sec. 2, Ch. 9

Physician: Sec. 2, Ch. 4 (see also Primary care doctor)

communicating with: Sec. 2, Ch. 8

in nursing home: Sec. 2, Ch. 14

office of: Sec. 2, Ch. 9

types of: Sec. 2, Ch. 9; Sec. 2, Ch. 9

Pick's disease: Sec. 3 Ch. 27 [sidebar]

Pilocarpine: Sec. 3, Ch. 39

Pimozide: Sec. 3, Ch. 32

Pindolol: Sec. 3, Ch. 46

Pineal gland: Sec. 2, Ch. 7

Pinna: Sec. 3, Ch. 37; Sec. 3, Ch. 37

Pioglitazone: Sec. 3, Ch. 34

Pituitary gland: Sec. 3 Ch. 33 [detail]

Plantar fasciitis: Sec. 3, Ch. 40

Plaque

amyloid (senile)

     in Alzheimer's disease: Sec. 3, Ch. 27

atherosclerotic

     in stroke: Sec. 3, Ch. 28; Sec. 3 Ch. 28 [detail]

dental: Sec. 3, Ch. 39; Sec. 3, Ch. 39

Plaques

atherosclerotic: Sec. 3, Ch. 44; Sec. 3, Ch. 44

     in coronary artery disease: Sec. 3, Ch. 45

Plasma cells: Sec. 3, Ch. 51

Plasma: Sec. 3, Ch. 49

Platelet(s): Sec. 3, Ch. 49

in blood clotting: Sec. 3, Ch. 49

high blood levels of (thrombocythemia): Sec. 3, Ch. 49

low levels of (thrombocytopenia): Sec. 3, Ch. 49; Sec. 3, Ch. 49

transfusion of: Sec. 3, Ch. 49

Plateletpheresis: Sec. 3, Ch. 49

Pleural space

air in: Sec. 3, Ch. 53

Pneumatic stockings

in deep vein thrombosis: Sec. 3, Ch. 44

after stroke: Sec. 3, Ch. 28

Pneumaturia: Sec. 3, Ch. 56

Pneumococcal pneumonia: Sec. 3, Ch. 52

vaccine for: Sec. 3, Ch. 52

Pneumonia: Sec. 3, Ch. 52

aspiration: Sec. 3, Ch. 17; Sec. 3, Ch. 52

     with swallowing disorders: Sec. 3, Ch. 54

in COPD: Sec. 3, Ch. 53

pneumococcal: Sec. 3, Ch. 52

     vaccine for: Sec. 3, Ch. 52; Sec. 2, Ch. 4

risk factors for: Sec. 3, Ch. 52

Podiatrist: Sec. 2 Ch. 09 [sidebar]

Poisoning

food: Sec. 3, Ch. 55

Polio

muscle weakness after (postpolio syndrome): Sec. 3, Ch. 29

Polyarteritis nodosa

blood clots with: Sec. 3, Ch. 49

Polycythemia vera: (see Polycythemia)

Polycythemia: Sec. 3, Ch. 49

in COPD: Sec. 3, Ch. 53

secondary: Sec. 3 Ch. 49 [sidebar]

Polydipsia: Sec. 3, Ch. 34

Polyethylene glycol: Sec. 3, Ch. 55

Polymyalgia rheumatica: Sec. 3, Ch. 42

Polyphagia: Sec. 3, Ch. 34

Polyps

large intestine: Sec. 3, Ch. 51

nasal: Sec. 3, Ch. 38; Sec. 3, Ch. 38

Polysomnography: Sec. 2, Ch. 10; Sec. 3, Ch. 31

Polyuria: Sec. 3, Ch. 34

Pool

exercise in: Sec. 3, Ch. 60; Sec. 3, Ch. 60; Sec. 3, Ch. 60

Popliteal artery: Sec. 3, Ch. 44

Population

aging: Sec. 1, Ch. 3

Portal hypertension

in myelofibrosis: Sec. 3, Ch. 49

Positron emission tomography: Sec. 2, Ch. 10

in Parkinson's disease: Sec. 3, Ch. 30

Postherpetic neuralgia: Sec. 3, Ch. 24; Sec. 3, Ch. 35

Postpolio syndrome: Sec. 3, Ch. 29

Postprandial hypotension: Sec. 3, Ch. 20; Sec. 3, Ch. 20

Posttraumatic stress disorder: Sec. 3 Ch. 32 [detail]

Postural tremor: Sec. 3 Ch. 30 [sidebar]

Potassium channel blockers: Sec. 3, Ch. 47

Potassium

deficiency of: Sec. 3, Ch. 17

in heart failure: Sec. 3, Ch. 46

high levels of (hyperkalemia): Sec. 3, Ch. 18

low levels of (hypokalemia): Sec. 3, Ch. 18

supplemental: Sec. 3, Ch. 18

     esophageal damage with: Sec. 3, Ch. 54

Poverty: Sec. 1, Ch. 3

Power of attorney for health care: Sec. 1, Ch. 3; Sec. 2, Ch. 12; Sec. 2, Ch. 16; Sec. 4, Ch. 65

PPO: (see Preferred provider organization)

Pramipexole: Sec. 3, Ch. 30; Sec. 3, Ch. 30

Pravastatin: Sec. 3, Ch. 44

in coronary artery disease: Sec. 3, Ch. 45; Sec. 3, Ch. 45

Prazosin

in high blood pressure: Sec. 3, Ch. 43

urinary incontinence with: Sec. 3, Ch. 57

Prednisolone: Sec. 3, Ch. 41

Prednisone

in gout: Sec. 3, Ch. 41; Sec. 3, Ch. 41

in idiopathic thrombocytopenic purpura: Sec. 3, Ch. 49

in multiple myeloma: Sec. 3, Ch. 51

in myelofibrosis: Sec. 3, Ch. 49

in polymyalgia rheumatic: Sec. 3, Ch. 42

in rheumatoid arthritis: Sec. 3, Ch. 41

in temporal arteritis: Sec. 3, Ch. 42

Preferred provider organization: Sec. 4, Ch. 66

Premature atrial beats: Sec. 3, Ch. 47; Sec. 3, Ch. 47

Premature ventricular beats: Sec. 3, Ch. 47; Sec. 3, Ch. 47

Presbycusis: Sec. 3, Ch. 37

dizziness and: Sec. 3, Ch. 20

Presbylarynx: Sec. 3, Ch. 38; Sec. 3, Ch. 38

Presbyopia: Sec. 1, Ch. 2

Pressure sores: Sec. 3, Ch. 35

with assistive devices: Sec. 2, Ch. 13

during bed rest: Sec. 2, Ch. 11

in dying person: Sec. 2, Ch. 16

prevention of: Sec. 3, Ch. 35

after stroke: Sec. 3, Ch. 28

Pressure

blood: (see Blood pressure; High blood pressure; Low blood pressure)

eye (intraocular): Sec. 3, Ch. 36

Prevalence: Sec. 2, Ch. 10

Prevention: Sec. 2, Ch. 4

of atherosclerosis: Sec. 3, Ch. 44

of cataracts: Sec. 3, Ch. 36

of constipation: Sec. 3, Ch. 55

of corns and calluses: Sec. 3, Ch. 40

of coronary artery disease: Sec. 3, Ch. 45

of deep vein thrombosis: Sec. 3, Ch. 44

of delirium: Sec. 3, Ch. 26

of dental disease: Sec. 3, Ch. 39

of diabetes: Sec. 3, Ch. 34

of fainting: Sec. 3, Ch. 20

of falls: Sec. 3, Ch. 21; Sec. 3, Ch. 23

of fractures: Sec. 3, Ch. 21; Sec. 3, Ch. 23; Sec. 3, Ch. 23

goals of: Sec. 2, Ch. 4

of gout: Sec. 3, Ch. 41

healthy lifestyle for: Sec. 2, Ch. 4

of hearing loss: Sec. 3 Ch. 37 [sidebar]

of hyperthermia: Sec. 3, Ch. 19

of influenza: Sec. 3, Ch. 52

of lung cancer: Sec. 3, Ch. 51

managed care for: Sec. 4, Ch. 66

of mistreatment: Sec. 4, Ch. 64

of osteoarthritis: Sec. 3, Ch. 41

of periodontal disease: Sec. 3, Ch. 39

of pneumonia: Sec. 3, Ch. 52

of pressure sores: Sec. 3, Ch. 35

of problems in hospital: Sec. 2, Ch. 11

of pulmonary embolism: Sec. 3, Ch. 44

of stroke: Sec. 3, Ch. 28

of tooth decay: Sec. 3, Ch. 39

of undernutrition: Sec. 3, Ch. 17

of urinary tract infection: Sec. 3, Ch. 56

of venous ulcers: Sec. 3, Ch. 35

of vulvar skin disorders: Sec. 3, Ch. 58

Primary care doctor: Sec. 2, Ch. 4

communicating with: Sec. 2, Ch. 8

emergency department care and: Sec. 2, Ch. 11

patient information for: Sec. 2, Ch. 8; Sec. 2, Ch. 8

selection of: Sec. 2, Ch. 8; Sec. 2, Ch. 8

visit to: Sec. 2, Ch. 8; Sec. 2, Ch. 8

Primidone: Sec. 3, Ch. 30

Privacy: Sec. 4, Ch. 63

Private health care insurance: Sec. 4, Ch. 66

Probenecid: Sec. 3, Ch. 41; Sec. 3, Ch. 41

Procainamide: Sec. 3, Ch. 47

Procedures: (see Test[s])

Procidentia: Sec. 3, Ch. 58; Sec. 3, Ch. 58

Progesterone

postmenopausal levels of: Sec. 3, Ch. 58

receptors for

     in breast cancer: Sec. 3, Ch. 51; Sec. 3, Ch. 51

Progestin: Sec. 3, Ch. 22

Program of All-Inclusive Care for the Elderly: Sec. 4, Ch. 66

Progressive supranuclear palsy: Sec. 3, Ch. 30

dementia in: Sec. 3 Ch. 27 [sidebar]

Prolapse: (see Pelvic support disorders)

Promethazine: Sec. 2, Ch. 6

Propafenone: Sec. 3, Ch. 47; Sec. 3, Ch. 47

Propantheline: Sec. 2, Ch. 6

Propoxyphene: Sec. 2, Ch. 6

Propranolol

in abnormal heart rhythms: Sec. 3, Ch. 47

in coronary artery disease: Sec. 3, Ch. 45

in heart failure: Sec. 3, Ch. 46

in high blood pressure: Sec. 3, Ch. 43

in Shy-Drager syndrome: Sec. 3, Ch. 30

in tremor: Sec. 3, Ch. 30

Propylthiouracil: Sec. 3, Ch. 33

Prostate gland

benign hyperplasia of: Sec. 3, Ch. 59

     urinary tract infection with: Sec. 3, Ch. 56

biopsy of: Sec. 2, Ch. 10; Sec. 3, Ch. 51

cancer of: Sec. 3, Ch. 51

     information resources on: 884

     screening for: Sec. 3, Ch. 50; Sec. 3, Ch. 51

     screening for: Sec. 2, Ch. 4

     watchful waiting in: Sec. 3, Ch. 51

enlargement of: Sec. 1, Ch. 2 (see Prostate gland, benign hyperplasia of)

examination of: Sec. 3, Ch. 59

infection of: Sec. 3, Ch. 56; Sec. 3, Ch. 59

     information resources on: 888

inflammation of: Sec. 3, Ch. 59

     information resources on: 888

removal of: (see Prostatectomy)

saw palmetto effects on: Sec. 2, Ch. 7

transurethral resection of (TURP): Sec. 3, Ch. 59

     erectile dysfunction and: Sec. 3 Ch. 59 [detail]

Prostate-specific antigen (PSA): Sec. 3, Ch. 50; Sec. 3, Ch. 51; Sec. 3, Ch. 59

Prostatectomy: Sec. 3, Ch. 51

erectile dysfunction and: Sec. 3 Ch. 59 [detail]

Prostatitis: Sec. 3, Ch. 56; Sec. 3, Ch. 59

information resources on: 888

Prosthesis

leg: Sec. 2, Ch. 13

Prosthetist: Sec. 2 Ch. 09 [sidebar]

Protease inhibitors

St. John's wort interaction with: Sec. 2, Ch. 7

Protein C deficiency: Sec. 3, Ch. 49

Protein S deficiency: Sec. 3, Ch. 49

Protein(s)

Bence Jones: Sec. 3, Ch. 51

dietary: Sec. 2, Ch. 5

Proteus infection: Sec. 3, Ch. 52

Prothrombin G20210A polymorphism: Sec. 3, Ch. 49

Proxy: (see Durable power of attorney for health care)

Pruritus: (see Itching)

PSA (prostate-specific antigen): Sec. 3, Ch. 50; Sec. 3, Ch. 51; Sec. 3, Ch. 59

Pseudobulbar palsy

swallowing difficulty in: Sec. 3, Ch. 54

Pseudodementia: Sec. 3, Ch. 32

Pseudoephedrine

in stress incontinence: Sec. 3, Ch. 57

urinary incontinence with: Sec. 3, Ch. 57

Pseudogout: Sec. 3, Ch. 41

Pseudohypertension: Sec. 3, Ch. 43

Pseudomonas aeruginosa infection: Sec. 3, Ch. 52

Psoriasis

of vulva: Sec. 3, Ch. 58

Psychiatrist: Sec. 2, Ch. 9

Psychologic abuse: Sec. 4, Ch. 64

Psychologic age: Sec. 1, Ch. 1

Psychologic factors

function and: Sec. 1, Ch. 1

undernutrition and: Sec. 3 Ch. 17 [detail]

Psychologist: Sec. 2 Ch. 09 [sidebar]

Psychosis: Sec. 3, Ch. 32

depression with: Sec. 3, Ch. 32

in Lewy body dementia: Sec. 3, Ch. 27

in intensive care unit: Sec. 2, Ch. 11

Psychostimulants

in depression: Sec. 3, Ch. 32

Psychotherapy

in anxiety: Sec. 3, Ch. 32

in depression: Sec. 3, Ch. 32

Psyllium

in constipation: Sec. 3, Ch. 55; Sec. 3, Ch. 55

in diarrhea: Sec. 3, Ch. 55

Ptosis (eyelid droop): Sec. 3, Ch. 36

Pulmonary (pulmonic) valve: Sec. 3, Ch. 45; Sec. 3, Ch. 48

Pulmonary artery: Sec. 3, Ch. 44; Sec. 3, Ch. 44

angiography of: Sec. 3, Ch. 44

Pulmonary edema

in heart failure: Sec. 3, Ch. 45; Sec. 3, Ch. 46; Sec. 3, Ch. 46

Pulmonary embolism

bed rest and: Sec. 3, Ch. 23

in deep vein thrombosis: Sec. 3, Ch. 44; Sec. 3, Ch. 44

prevention of: Sec. 3, Ch. 44; Sec. 3, Ch. 44

Pulmonary fibrosis: Sec. 3 Ch. 46 [detail]

Pulmonary vein: Sec. 3, Ch. 44

Pulmonologist: Sec. 2, Ch. 9

Pulse oximetry

in COPD: Sec. 3, Ch. 53

in deep vein thrombosis: Sec. 3, Ch. 44

Pulse

in peripheral arterial disease: Sec. 3, Ch. 44

Punch biopsy: Sec. 2, Ch. 10

Pupil

aging of: Sec. 1, Ch. 2

Purple coneflower: Sec. 2, Ch. 7

drug interactions with: Sec. 2, Ch. 7

Pyelonephritis: Sec. 3, Ch. 56; Sec. 3, Ch. 56; Sec. 3, Ch. 56